MARLBOROUGH, Mass., Jan. 12, 2018 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced positive results from the WHISPER randomized controlled trial (RCT). The data, presented at the 2018 Annual Meeting of the North American Neuromodulation Society in Las Vegas, demonstrated that patients who are given the choice to use both sub-perception and paresthesia-based spinal cord stimulation (SCS) therapy achieve superior […]
All News
GEORGETOWN, TEXAS (PRWEB) JANUARY 11, 2018 Last month, the Food and Drug Administration cleared ReBOSSIS®, the only biosynthetic bone scaffold with electrospun microfiber construction, for use in posterolateral spine procedures. “Having ReBOSSIS® used in these types of procedures reaffirms its place in today’s biologic market,” says Doris Blake, president and COO of ORTHOReBIRTH USA, a wholly […]
Aliso Viejo, CA, Jan. 10, 2018 (GLOBE NEWSWIRE) — OrthAlign, Inc., a leading provider of orthopedic surgical navigation solutions, announced today that Dr. Steven Haas, Chief of the Knee Service at Hospital for Special Surgery in New York, NY, has joined the company’s Executive Surgeon Council (“ESC”) advisory board. The ESC works closely with OrthAlign’s […]
January 10, 2018 SAN LUIS OBISPO, Calif.–(BUSINESS WIRE)–FzioMed, Inc. a leading biomaterials company, is pleased to announce that Oxiplex sales have now passed the 500,000 unit mark. Oxiplex is approved outside the United States in more than 70 countries and distributed under various brand names; including, Oxiplex, Oxiplex/SP, MediShield, and Interpose. Oxiplex is an absorbable […]
January 10, 2018 POMPANO BEACH, Fla.–(BUSINESS WIRE)–Stimwave LLC, a medical device manufacturer and independent research institute headquartered in Pompano Beach, Fla., has agreed to over $50 million in additional financing from undisclosed investors to fuel the consumer launch of the world’s first wireless, micro-technology, drug-free neuromodulation device for relief of chronic pain. Stimwave offers the […]
WASHINGTON, Jan. 10, 2018 /PRNewswire-USNewswire/ — Musculoskeletal Clinical Regulatory Advisers, LLC (MCRA) has announced its role in the successful de novo clearance by the U.S. Food and Drug Administration (FDA) on December 28, 2017 enabling SANUWAVE Health, Inc. to initiate commercialization of the dermaPACE System for the treatment of Diabetic Foot Ulcers (DFU) in the U.S. SANUWAVE retained MCRA in January of […]
© 2025 MedDeviceJobs.com | Powered by Careerleaf
v.4.6.7-9-gdb70438